Samsung Bioepis' Corporate Minority Round

Samsung Bioepis raised a round of funding on February 12, 2012. Investors include Biogen.

Samsung Bioepis develops high-quality biologic medicines that increase patient access to effective treatment.…

Articles about Samsung Bioepis' Corporate Minority Round: